Advanced search
Publication Cover
Australian and New Zealand Journal of Psychiatry Volume 44, 2010 - Issue 1
Journal homepage
66
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Selection of reference gene expression in a schizophrenia brain cohort

Cynthia Shannon Weickert Schizophrenia Research Institute, Sydney, New South Wales, Australia; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia; Schizophrenia Research Laboratory, Prince of Wales Medical Research Institute, SRL – 1st Floor, Corner of Barker and Easy Streets, Randwick, NSW 2031, Australia.Correspondence[email protected]
(Macquarie Chair of Schizophrenia Research) ,
Donna Sheedy New South Wales Tissue Resource Centre, Department of Pathology, School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia
(Research Manager) ,
Debora A. Rothmond Schizophrenia Research Institute, Sydney, New South Wales, Australia; Schizophrenia Research Laboratory, Prince of Wales Medical Research Institute, Randwick, New South Wales, Australia
(Senior Research Assistant) ,
Irina Dedova Schizophrenia Research Institute, Sydney, New South Wales, Australia; New South Wales Tissue Resource Centre, Department of Pathology, School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia
(Senior Research Officer) ,
Samantha Fung Schizophrenia Research Institute, Sydney, New South Wales, Australia; Schizophrenia Research Laboratory, Prince of Wales Medical Research Institute, Randwick, New South Wales, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia
(Research Officer) ,
Therese Garrick New South Wales Tissue Resource Centre, Department of Pathology, School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia
(TRC Manager) ,
Jenny Wong Schizophrenia Research Institute, Sydney, New South Wales, Australia; Schizophrenia Research Laboratory, Prince of Wales Medical Research Institute, Randwick, New South Wales, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia
(Research Officer) ,
Antony J. Harding New South Wales Tissue Resource Centre, Department of Pathology, School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia
(Senior Research Officer) ,
Sinthuja Sivagnanansundaram Schizophrenia Research Institute, Sydney, New South Wales, Australia; Schizophrenia Research Laboratory, Prince of Wales Medical Research Institute, Randwick, New South Wales, Australia
(Senior Research Officer) ,
Clare Hunt New South Wales Tissue Resource Centre, Department of Pathology, School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia
(Research Assistant) ,
Carlotta Duncan Schizophrenia Research Institute, Sydney, New South Wales, Australia; Schizophrenia Research Laboratory, Prince of Wales Medical Research Institute, Randwick, New South Wales, Australia
(Research Officer) ,
Nina Sundqvist Schizophrenia Research Institute, Sydney, New South Wales, Australia; New South Wales Tissue Resource Centre, Department of Pathology, School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia
(Clinical Liaison Officer) ,
Shan-Yuan Tsai Schizophrenia Research Institute, Sydney, New South Wales, Australia; Schizophrenia Research Laboratory, Prince of Wales Medical Research Institute, Randwick, New South Wales, Australia
(Research Assistant) ,
Jasna Anand New South Wales Tissue Resource Centre, Department of Pathology, School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia
(Research Assistant) ,
Daren Draganic Schizophrenia Research Institute, Sydney, New South Wales, Australia
(SRI Director of Operations) &
Clive Harper New South Wales Tissue Resource Centre, Department of Pathology, School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia
(TRC Director) show all
Pages 59-70 | Received 09 Jun 2009, Accepted 29 Jun 2009, Published online: 14 Jan 2010

References

  • Kleinman JE, Hyde TM, Herman MM. Methodological issues in the neuropathology of mental illness. Bloom FE, Kupfer DJ, Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995:859–864.
  • Lewis DA. The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacology 2002; 26:143–154.
  • Ravid R, Van Zwieten EJ, Swaab DF. Brain banking and the human hypothalamus: factors to match for, pitfalls and potentials. Prog Brain Res 1992; 93:83–95.
  • Bahn S, Augood SJ, Ryan M, Standaert DG, Starkey M, Emson PC. Gene expression profiling in the post-mortem human brain: no cause for dismay. J Chem Neuroanat 2001; 22:79–94.
  • Bunney WE, Bunney BG, Vawter MP . Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry 2003; 160:657–666.
  • Lipska BK, Deep-Soboslay A, Weickert CS . Critical factors in gene expression in postmortem human brain: focus on studies in schizophrenia. Biol Psychiatry 2006; 60:650–658.
  • Siegmund KD, Connor CM, Campan M . DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2007; 2:e895.
  • Weis S, Llenos IC, Dulay JR, Elashoff M, Martinez-Murillo F, Miller CL. Quality control for microarray analysis of human brain samples: the impact of postmortem factors, RNA characteristics, and histopathology. J Neurosci Methods 2007; 165:198–209.
  • Monoranu CM, Apfelbacher M, Grunblatt E . pH measurement as quality control on human postmortem brain tissue: a study of the BrainNet Europe Consortium. Neuropathol Appl Neurobiol 2009; 35:329–337.
  • Chevyreva I, Faull RL, Green CR, Nicholson LF. Assessing RNA quality in postmortem human brain tissue. Exp Mol Pathol 2008; 84:71–77.
  • Johnston NL, Cervenak J, Shore AD, Torrey EF, Yolken RH. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium. J Neurosci Methods 1997; 77:83–92.
  • Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10:40–68.
  • Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000; 28:53–67.
  • Perlman WR, Weickert CS, Akil M, Kleinman JE. Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes. J Psychiatry Neurosci 2004; 29:287–293.
  • Pongrac J, Middleton FA, Lewis DA, Levitt P, Mirnics K. Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem Res 2002; 27:1049–1063.
  • Tamminga CA, Holcomb HH. Phenotype of schizophrenia: a review and formulation. Mol Psychiatry 2005; 10:27–39.
  • Lewis DA, Gonzalez-Burgos G. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 2008; 33:141–165.
  • Draganic DM, Catts SV, Carr VJ. Neuroscience Institute of Schizophrenia and Allied Disorders (NISAD): 10 years of Australia's first virtual research institute. Aust N Z J Psychiatry 2007; 41:78–88.
  • Kozlovsky N, Shanon-Weickert C, Tomaskovic-Crook E, Kleinman JE, Belmaker RH, Agam G. Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients. J Neural Transm 2004; 111:1583–1592.
  • Schroeder A, Mueller O, Stocker S . The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006;7:3.
  • Law AJ, Kleinman JE, Weinberger DR, Weickert CS. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet 2007; 16:129–141.
  • Silberberg G, Baruch K, Navon R. Detection of stable reference genes for real-time PCR analysis in schizophrenia and bipolar disorder. Anal Biochem 2009; 391:91–97.
  • Wong J, Weickert CS. Transcriptional interaction of an estrogen receptor splice variant and ErbB4 suggests convergence in gene susceptibility pathways in schizophrenia. J Biol Chem 2009; 284:18 824–18 832.
  • Vandesompele J, De Preter K, Pattyn F . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3(7): RESEARCH0034.
  • Bustin SA, Benes V, Nolan T, Pfaffl MW. Quantitative real-time RT-PCR: a perspective. J Mol Endocrinol 2005; 34:597–601.
  • Stan AD, Ghose S, Gao XM . Human postmortem tissue: what quality markers matter? Brain Res 2006; 1123:1–11.
  • Webster MJ. Tissue preparation and banking. Prog Brain Res 2006; 158:3–14.
  • Mexal S, Berger R, Adams CE, Ross RG, Freedman R, Leonard S. Brain pH has a significant impact on human postmortem hippocam-pal gene expression profiles. Brain Res 2006; 1106:1–11.
  • Schoor O, Weinschenk T, Hennenlotter J . Moderate degradation does not preclude microarray analysis of small amounts of RNA. Biotechniques 2003; 35:1192–1196, 1198–1201.
  • Barton AJ, Pearson RC, Najlerahim A, Harrison PJ. Pre- and postmortem influences on brain RNA. J Neurochem 1993; 61: 1–11.
  • Ervin JF, Heinzen EL, Cronin KD . Postmortem delay has minimal effect on brain RNA integrity. J Neuropathol Exp Neurol 2007; 66:1093–1099.
  • Kingsbury AE, Foster OJ, Nisbet AP . Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 1995; 28:311–318.
  • Schramm M, Falkai P, Tepest R . Stability of RNA transcripts in post-mortem psychiatric brains. J Neural Transm 1999; 106:329–335.
  • Trotter SA, Brill Ii LB, Bennett JP. Stability of gene expression in postmortem brain revealed by cDNA gene array analysis. Brain Res 2002; 942:120–123.
  • Catts VS, Catts SV, Fernandez HR, Taylor JM, Coulson EJ, Lutze-Mann LH. A microarray study of post-mortem mRNA degradation in mouse brain tissue. Brain Res Mol Brain Res 2005; 138:164–177.
  • Atz M, Walsh D, Cartagena P . Methodological considerations for gene expression profiling of human brain. J Neurosci Methods 2007; 163:295–309.
  • Auer H, Lyianarachchi S, Newsom D, Klisovic MI, Marcucci G, Kornacker K. Chipping away at the chip bias: RNA degradation in microarray analysis. Nat Genet 2003; 35:292–293.
  • Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 1995; 200:151–154.
  • Miller CL, Diglisic S, Leister F, Webster M, Yolken RH. Evaluating RNA status for RT-PCR in extracts of postmortem human brain tissue. Biotechniques 2004; 36:628–633.
  • Preece P, Cairns NJ. Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res 2003; 118:60–71.
  • Li JZ, Meng F, Tsavaler L . Sample matching by inferred agonal stress in gene expression analyses of the brain. BMC Genomics 2007;8:336.
  • Tomita H, Vawter MP, Walsh DM . Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry 2004; 55:346–352.
  • Vawter MP, Tomita H, Meng F . Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry 2006; 11:615, 663–679.
  • Hardy JA, Wester P, Winblad B, Gezelius C, Bring G, Eriksson A. The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J Neural Transm 1985; 61:253–264.
  • Li JZ, Vawter MP, Walsh DM . Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 2004; 13:609–616.
  • Hashimoto T, Arion D, Unger T . Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 2008; 13:147–161.
  • Harrison PJ, Freemantle N, Geddes JR. Meta-analysis of brain weight in schizophrenia. Schizophr Res 2003; 64:25–34.
  • DeLisi LE, Sakuma M, Maurizio AM, Relja M, Hoff AL. Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res 2004; 130:57–70.
  • DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 1997; 74:129–140.
  • Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 2005; 30:1649–1661.
  • Konopaske GT, Dorph-Petersen KA, Pierri JN, Wu Q, Sampson AR, Lewis DA. Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology 2007; 32:1216–1223.
  • Johnston-Wilson NL, Sims CD, Hofmann JP . Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry 2000; 5:142–149.
  • Steffek AE, McCullumsmith RE, Haroutunian V, Meador-Woodruff JH. Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia. Schizophr Res 2008; 103:71–82.
  • Toro CT, Hallak JE, Dunham JS, Deakin JF. Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder. Neurosci Lett 2006; 404: 276–281.
  • Webster MJ, O'Grady J, Kleinman JE, Weickert CS. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience 2005; 133:453–461.
  • Damadzic R, Bigelow LB, Krimer LS . A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis. Brain Res Bull 2001; 55:611–618.
  • Dean B, Gray L, Scarr E. Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia. Aust N Z J Psychiatry 2006; 40:217–224.
  • Dean B, Keriakous D, Scarr E, Thomas EA. Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia. Aust N Z J Psychiatry 2007; 41:308–320.
  • Lauriat TL, Dracheva S, Chin B, Schmeidler J, McInnes LA, Haroutunian V. Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain. Neuroscience 2006; 137:843–851.
  • O'Connor JA, Muly EC, Arnold SE, Hemby SE. AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs. Schizophr Res 2007; 90:28–40.
  • Johansson S, Fuchs A, Okvist A . Validation of endogenous controls for quantitative gene expression analysis: application on brain cortices of human chronic alcoholics. Brain Res 2007; 1132:20–28.
  • Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE, Weinberger DR. Expression analysis of neuregulin-1 in the dorso-lateral prefrontal cortex in schizophrenia. Mol Psychiatry 2004; 9:299–307.
  • Weickert CS, Straub RE, McClintock BW . Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 2004; 61:544–555.
  • Weickert CS, Webster MJ, Hyde TM. Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia. Cereb Cortex 2001; 11:136–147.
  • Bayley JP, Devilee P, Taschner PE. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet 2005;6:39.
  • Horvath R, Abicht A, Holinski-Feder E . Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA). J Neurol Neurosurg Psychiatry 2006; 77:74–76.
  • Finsterer J. Cognitive decline as a manifestation of mitochondrial disorders (mitochondrial dementia). J Neurol Sci 2008; 272:20–33.
  • Holmes E, Tsang TM, Huang JT . Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med 2006; 3:e327.
  • Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 2002; 22:2718–2729.
  • Mimmack ML, Brooking J, Bahn S. Quantitative polymerase chain reaction: validation of microarray results from postmortem brain studies. Biol Psychiatry 2004; 55:337–345.
  • Tomatsu S, Montano AM, Dung VC, Grubb JH, Sly WS. Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome). Hum Mutat 2009; 30:511–519.

References

  • Deep-Soboslay A, Akil M, Martin CE, Bigelow LB, Herman MM, Hyde TM, Kleinman JE. Reliability of psychiatric diagnosis in postmortem research. Biol Psychiatry 2005; 57:96–101.
  • Garrick T, Howell S, Terwee P, Redenbach J, Blake H, Harper C. Brain donation for research: who donates and why? J Clin Neurosci 2006; 13:524–8.
  • Hill C, Keks N, Roberts S, Opeskin K, Dean B, MacKinnon A, Copolov D. Problem of diagnosis in postmortem brain studies of schizophrenia. Am J Psychiatry 1996; 153:533–7.
  • Sundqvist N, Garrick T, Bishop I, Harper C. Reliability of postmortem psychiatric diagnosis for neuroscience research. Aust N Z J Psychiatry 2008; 42:221–7.
  • Sards M, Garrick TM, Sheedy D, Harper CG. Banking for the future: an Australian experience in brain banking. Pathology 2002; 34:225–9.
  • Sheedy D, Garrick T, Dedova I, Hunt C, Miller R, Sundqvist N, Harper C. An Australian Brain Bank: a critical investment with a high return! Cell Tissue Bank 2008; 9:205–16.
  • Hardy JA, Wester P, Winblad B, Gezelius C, Bring G, Eriksson A. The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J Neural Transm 1985; 61:253–64.
  • Tomita H, Vawter MP, Walsh DM, Evans SJ, Choudary PV, Li J, Overman KM, Atz ME, Myers RM, Jones EG, Watson SJ, Akil H, Bunney WE, Jr. Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry 2004; 55:346–52.
  • Harper CG, Kril JJ, Daly JM. Brain shrinkage in alcoholics is not caused by changes in hydration: a pathological study. J Neurol Neurosurg Psychiatry 1988; 51:124—7.
  • Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 1995; 200:151—4.
  • Kingsbury AE, Foster OJ, Nisbet AP, Cairns N, Bray L, Eve DJ, Lees AJ, Marsden CD. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 1995;28:311–8.
  • Stan AD, Ghose S, Gao XM, Roberts RC, Lewis-Amezcua K, Hatanpaa KJ, Tamminga CA. Human postmortem tissue: what quality markers matter? Brain Res 2006; 1123:1–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.